Dianthus stockholders elect directors, approve say-on-pay, ratify Deloitte at 2026 annual meeting

Dianthus Therapeutics, Inc. /DE/

Sujay Kango, Anne McGeorge, and Jonathan Violin elected Class II directors with 42.7M, 34.8M, and 42.8M votes for, respectively.
Advisory vote on executive compensation passed: 41.0M for, 1.7M against, 0.5M abstain, 3.6M broker non-votes.
Ratification of Deloitte & Touche as auditor for 2026 approved: 46.3M for, 5.3K against, 0.5M abstain, no broker non-votes.
All three proposals passed with substantial majorities; no material changes to governance disclosed.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Dianthus Therapeutics, Inc. /DE/ shareholders approved Election of Class II Directors at the 2026-05-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Nominees For Withheld Broker Non-Votes Sujay Kango 42,739,315 479,199 3,585,554 Anne McGeorge 34,814,377 8,404,137 3,585,554 Jonathan Violin, Ph.D 42,799,946 418,568 3,585,554

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.99

Dianthus Therapeutics, Inc. /DE/ shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

For Against Abstain Broker Non-Votes 46,298,319 5,279 500,471 —

View on SEC.gov

483 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Dianthus Therapeutics, Inc. /DE/ filing history →

Source: SEC EDGAR

accession 0001690585-26-000026

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.